Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 12 May 2009, doi:10.1136/bmj.b1916
Cite this as: BMJ 2009;338:b1916
| The first 150 words of the full text of this article appear below. |
Diabetes has become an industry, with a host of jobs ultimately dependent on the idea that intensive treatment will achieve better outcomes.1
I believe that many patients have been overtreated by doctors and nurses to hit the previous targets of the quality and outcomes framework (QOF). These patients have had severe hypoglycaemic episodes and gained a lot of weight (that they will probably never lose). In my experience, many obese patients starting insulin treatment will progress to morbid obesity, sleep apnoea syndrome, fatty liver disease, cirrhosis, severe osteoarthritis, and premature death. The new targets are a lot harder and will inevitably lead to more insulin, more hypoglycaemic episodes, more obesity.
That no QOF targets apply to specialist clinics is puzzling. If they did, I suspect that they would not be hit and the enthusiasm for the QOF would wane.
Observational studies do show a strong association between abnormal blood glucose
Ted Willis, general practitioner1
1 Brigg, North Lincolnshire
ted.willis@nlpct.nhs.uk